Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Minimum severity
Pending LLM rewrite. Source: FDA_FOOD H-0844-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0822-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0783-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0812-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0826-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0807-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0791-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0838-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0790-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0785-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0800-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0797-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0848-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0809-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0798-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0825-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0794-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0813-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0793-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0828-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0786-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0810-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0796-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0841-2026.
Lupin Pharmaceuticals is recalling Liraglutide Injection due to the presence of white thread-like structures (particulate matter) found in cartridges. The recall affects 217,621 pen injectors distributed nationwide.